European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 5) monitoring access to biosimilars. Senate Bill 562 (S.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. appeared first on Pharma Marketing Network.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

Pharma Leaders

MAY 18, 2023

The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmitted New Drug Application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adult patients with chronic kidney disease on dialysis who have had an insufficient response or intolerance to a phosphate binder therapy.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52

Contrarian Sales Techniques

DECEMBER 14, 2022

The biotechnology and drug sectors performed well in the second half of 2022 after struggling in the first six months. Despite the uncertainty surrounding the global economy, the drug and biotechnology sectors have continued to perform well in the second half of 2022. What Influence the Future of the Large-Cap Pharma Industry?

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical Sales Medicine 52

Pharmaceutical Technology

SEPTEMBER 2, 2022

This is a result of intensive research efforts that have produced regimens that have prolonged patient survival, most of which are a combination of a proteasome inhibitor + an immunomodulatory drug (ie. lenalidomide) + a steroid ± an anti-CD38 antibody.

Food and Drug Administration 59

Food and Drug Administration FDA Sales Physicians 59

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. The list, designed to serve as a reference point for prioritized drug review and evaluation policies, included 121 rare diseases. [8]. 10] [11] [12].

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

pharmaphorum

OCTOBER 13, 2022

From developing and financing the therapy in a timely manner to market access challenges due to the lack of maturity and extensive evidence, and explaining the complex science to physicians and patients, there are a variety of hurdles to overcome before bringing this type of technology to market.

Food and Drug Administration 52

Food and Drug Administration Side effects Patients FDA 52

PM360

AUGUST 9, 2022

Sermo , a physician-first online community, found the tracks at ASCO that oncologists felt were the most transformative to be breast cancer (58%), lung cancer (34%), and developmental therapeutics—molecularly targeted agents and tumor biology (32%). EPA Administrator Michael Regan said the agency will take more aggressive action against PFAS.

Healthcare 52

Healthcare Healthcare Food and Drug Administration FDA 52

Pharmaceutical Technology

MAY 5, 2023

The sale of an illegally imported supplement being marketed as a weight-gain enhancer has been associated with cases of dizziness, cognitive impairment, and sedation, according to the US Food and Drug Administration (FDA).

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Food 52

Evolve Your Success

MAY 17, 2022

You know when they are trying to push a drug and white-knuckling it. When a physician decides to use a robotic machine, that is not part of my decision-making process and the OR manager. You ask the hospital administrators to figure out the financial aspects of that side of it. What drugs are we using? Sales can be pushy.

Medical sales 52

Medical sales Medical Sales Patients 52

pharmaphorum

OCTOBER 3, 2022

This typically sees higher-priced drugs, even in oncology, being sidelined in favour of biosimilars, off-patent branded drugs, or locally manufactured alternatives, unless manufacturers offer significant discounting to gain access to national essential medicines lists. However, even then, challenges could remain.

Food and Drug Administration 88

Food and Drug Administration Consulting Marketing Manufacturing 88

Evolve Your Success

FEBRUARY 7, 2023

I was working with the same physicians I used to sell stents to help them raise money and open their outpatient centers. We syndicate, which means we sell shares for physicians to invest. We’re partners with the physicians. The physicians come in, do their case and leave. The physicians like the efficiency.

Medical 52

Medical Sales Medical sales Doctors 52

Pharma Marketing Network

JUNE 11, 2020

With me, today is John Mack, the original creator of Pharma Marketing and also known as Pharma Guy from far and wide. And I was surprised to see a letter on the homepage that said, “Hey, Pharma folks, I’m retiring. And bring back some memories for folks of pharma guy and how he came to be. Thanks for coming John.

Media 52

Media Pharma Ethics Consulting 52

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. Proteus Health’s Abilify MyCite had an ingestible sensor that could track if a patient consumed the drug. Proteus’s profile grew considerably; it was soon valued at $1.5

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

Clarivate

MAY 24, 2023

Food and Drug Administration advisory committee’s narrow 8-6 vote in favor of recommending accelerated approval for a first-in-class gene transfer therapy was welcomed by Duchenne muscular dystrophy (DMD) patients and caregivers.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

European Pharmaceutical Review

DECEMBER 27, 2023

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. Being a cellular therapy that involves cell manipulation and molecular transfection – and above all, being a living drug – makes CAR T-cell therapy a somewhat challenging immunotherapy to manufacture in‑house.

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83

Cadensee

JULY 20, 2021

Basically, I started teaching myself how to get good information outside the internet and see how that empowers us with our discussion with a physician with everything that we did. It might be silly question but bringing a drug to market takes many, many years. So, I myself, was kind of tasked with go and search on the internet.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

World of DTC Marketing

JULY 20, 2021

Physicians have to be the first ones to break the resistance—the need to strongly urge patients to get vaccinated. Pharma companies and insurers also need to work together to spread the message showing what being sick with COVID are really like.

Food and Drug Administration 309

Food and Drug Administration Insurance Government Doctors 309